Evervie Health

Evervie Health signed a letter of intent with Elekta Solutions AB of Sweden on 20 October 2026 for the proposed procurement of ten HARMONY linear accelerator systems for an expected $11-15 million. The systems were proposed to be operated by its oncology subsidiary Optimus Oncology, with phased delivery of five units followed by five units tentatively to be completed by October 2028. The letter recorded a present commercial intention and did not constitute a definitive purchase agreement or oblige Elekta to supply, with execution subject to a definitive purchase and licence agreement, approvals and financing. Optimus Oncology was held at 56.01% after an acquisition in May 2025 for Rs 54.74 crore, alongside a 52% diagnostics subsidiary and a renal-care associate consolidated from January 2026. The company reported consolidated operating revenue of Rs 89.71 crore and a consolidated net loss of Rs 9.96 crore in the year to March 2026, with Rs 150 crore of secured listed debentures issued in April 2025. It also launched a new official website at everviehealth.com to replace pvpglobal.com following its change of name from PVP Ventures.

Powered by Tijori

Sept 24 (Reuters) - PVP Ventures Ltd PVPV.NS:

• ELLEN JANE FEEHAN RESIGNS AS & CEO

Further company coverage: PVPV.NS

(([email protected];))

Aug 17 (Reuters) - ** Shares of PVP Ventures PVPV.NS rise 6.7% to 37.8 rupees, their highest level since Jan. 1

** Real estate & healthcare services firm's consol net profit jumps to 120.8 million rupees ($1.27 million) from 2.9 million rupees ($30,386); rev rose to 456.4 million rupees from 172.1 million rupees

** Earnings were supported by a sharp rise in healthcare services revenue

** Stock down 3.3% YTD

($1 = 95.4400 Indian rupees)

(Reporting by Aleef Jahan in Bengaluru)

(([email protected];))

PVP Ventures announced on 3 July that it had deferred the principal repayment of its ₹150 crore non-convertible debentures by one year, from June 2026 to June 2027, after amending the debenture trust deed. The revision, approved by debenture holders and the National Stock Exchange, phases repayments in quarterly instalments starting June 2027. The two debenture series, held by LIC Housing Finance funds, were originally issued in April 2025 and carried a four-year tenor.

Powered by Tijori

March 30 (Reuters) - PVP Ventures Ltd PVPV.NS:

• BOARD APPROVES DIVESTMENT OF RESIDUAL EQUITY STAKE IN PICTUREHOUSE MEDIA

• CONSIDERATION RECEIVED FROM SALE IS 22 MILLION RUPEES

Source text: ID:nBSE2YJMtt

Further company coverage: PVPV.NS

(([email protected];;))

July 11 (Reuters) - PVP Ventures Ltd PVPV.NS:

• CO CHALLENGES NOTICE BY TAMIL NADU REGISTRATION DEPARTMENT

• HIGH COURT HAS SET ASIDE DEMAND NOTICE ISSUED BY DEPARTMENT OF REGISTRATION

Source text: ID:nBSE45WSfG

Further company coverage: PVPV.NS

(([email protected];;))

July 2 (Reuters) - PVP Ventures Ltd PVPV.NS:

• SUBSIDIARY SAFETRUNK SERVICES HAS BEEN STRUCK OFF

Source text: ID:nBSE7kcHzH

Further company coverage: PVPV.NS

(([email protected];;))

June 9 (Reuters) - PVP Ventures Ltd PVPV.NS:

• SEBI SEEKS CERTAIN CLARIFICATIONS, SUPPORTING DOCUMENTATION FROM CO

Source text: ID:nBSEby8MSq

Further company coverage: PVPV.NS

(([email protected];))

April 24 (Reuters) - PVP Ventures Ltd PVPV.NS:

• PVP VENTURES LTD - ACQUISITION OF 56% SHAREHOLDING IN OPTIMUS ONCOLOGY

• PVP VENTURES LTD - TO INVEST TOTAL SUM OF 550 MILLION RUPEES FOR ACQUISITION

Source text: [ID:]

Further company coverage: PVPV.NS

(([email protected];))

April 23 (Reuters) - PVP Ventures Ltd PVPV.NS:

• PVP VENTURES LTD - ACQUIRES 56% STAKE IN OPTIMUS ONCOLOGY

• PVP VENTURES LTD - TRANSACTION AMOUNTS TO 550 MILLION RUPEES FOR 56% STAKE IN OPTIMUS ONCOLOGY

• PVP VENTURES LTD - PLANS TO INCREASE STAKE TO 76% IN OPTIMUS ONCOLOGY OVER NEXT FEW YEARS

Source text: ID:nBSE2FgZWY

Further company coverage: PVPV.NS

(([email protected];;))

Feb 14 (Reuters) - PVP Ventures Ltd PVPV.NS:

• PVP VENTURES LTD - APPROVES MERGER WITH HUMAIN HEALTHTECH

Source text: ID:nNSE862S4h

Further company coverage: PVPV.NS

(([email protected];;))

June 21 (Reuters) - PVP Ventures Ltd PVPV.NS:

• PVP VENTURES LTD -SEBI ADJUDICATION ORDER PASSED AGAINST GO WITH PENALTY OF 1.4 MILLION RUPEES

Source text for Eikon: ID:nBSE4c7p1Y

Further company coverage: PVPV.NS

(([email protected];;))

** Shares of Brigade Enterprises BRIG.NS rise 3.7% to 1,041 rupees

** The real estate developer entered into a joint development agreement with PVP Ventures PVPV.NS to develop a 2.5 mln square feet high-rise residential project

** Shares of PVP Ventures up 4.8% to maximum exchange-allowed limit

** Brigade Group sees revenue potential of about 20 bln rupees ($241 million) from project

** Eleven analysts covering BRIG on avg have a "buy" rating; median PT is 1,125 rupees - LSEG data

** BRIG up ~1% so far in February, eyes fifth consecutive monthly gain

($1 = 82.9170 Indian rupees)

(Reporting by Ashna Teresa Britto in Bengaluru)

(([email protected] ; ( +91 8078332441))

Feb 13 (Reuters) - PVP Ventures Ltd PVPV.NS:

• NAMES K. ANAND KUMAR AS CFO

Source text for Eikon: ID:nBSE18vBbL

Further company coverage: PVPV.NS

(([email protected];;))

PVP Ventures Ltd PVPV.NS:

• PVP VENTURES LTD- RAMANI SABESAN RESIGNED AS CFO

Source text for Eikon: ID:nBSEWk5G0

Further company coverage: PVPV.NS

Aug 24 (Reuters) - PVP Ventures Ltd PVPV.NS:

• ACQUIRED HUMAIN HEALTHTECH FOR 225 MILLION RUPEES

• APPROVED ISSUE OF 12.9 MLN SHARES OF CO ON PREFERENTIAL BASIS

• APPROVED SALE OF 81% STAKE IN UNIT NEW CYBERABAD CITY PROJECTS TO PICTUREHOUSE MEDIA

• DEAL FOR 325.6 MLN RUPEES

Source text for Eikon: [ID:]

Further company coverage: PVPV.NS

(([email protected];))

July 4 (Reuters) - PVP Ventures Ltd PVPV.NS:

• ARJUN ANANTH NAMED WHOLE TIME DIRECTOR IN DESIGNATION OF CEO

Source text for Eikon: ID:nNSEbSHPN1

Further company coverage: PVPV.NS

(([email protected];))

June 19 (Reuters) - PVP Ventures Ltd PVPV.NS:

• TO CONSIDER ISSUE OF SHARES VIA PREFERENTIAL ISSUE FOR ACQUISITION OF CO IN HEALTHCARE BUSINESS

Source text for Eikon: ID:nBSEc6knnV

Further company coverage: PVPV.NS

(([email protected];;))

May 16 (Reuters) - PVP Ventures Ltd PVPV.NS:

• DEFERRED CONSIDERING PREFERENTIAL ISSUE TO ACQUIRE A COMPANY ENGAGED IN HEALTHCARE BUSINESS

Source text for Eikon: [ID:]

Further company coverage: PVPV.NS

(([email protected];))

May 11 (Reuters) - PVP Ventures Ltd PVPV.NS:

• TO CONSIDER PREFERENTIAL ISSUE

• ISSUE FOR PURPOSE OF ACQUISITION OF A COMPANY ENGAGED IN HEALTHCARE BUSINESS

Source text for Eikon: ID:nBSEF0p0z

Further company coverage: PVPV.NS

(([email protected];))

April 25 (Reuters) - PVP Ventures Ltd PVPV.NS:

• TO CONSIDER ISSUE OF EQUITY SHARES OF COMPANY BY WAY OF PREFERENTIAL ISSUE

• ISSUE FOR PURPOSE OF ACQUISITION OF A COMPANY ENGAGED IN HEALTHCARE BUSINESS

Source text for Eikon: ID:nBSE6sJwrd

Further company coverage: PVPV.NS

(([email protected];))